| TAF11 |
TAF11, TAF2I, PRO2134: Transcription initiation factor TFIID subunit 11 |
TAF12 |
TAF12, TAF15, TAF2J, TAFII20: Transcription initiation factor TFIID subunit 12 |
8.322 |
Evidence |
O
|
| HARS |
HARS, HRS: Histidyl-tRNA synthetase, cytoplasmic |
EEF1G |
EEF1G, EF1G, PRO1608: Elongation factor 1-gamma |
8.322 |
Evidence |
|
| PSMC2 |
PSMC2, MSS1: 26S protease regulatory subunit 7 |
TRAF6 |
TRAF6, RNF85: TNF receptor-associated factor 6 |
8.322 |
Evidence |
O
|
| TAF4 |
TAF4, TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135: Transcription initiation factor |
TAF1 |
IPI00149098 |
8.312 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
8.222 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
8.222 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
8.222 |
Evidence |
|
| LAT |
LAT: Linker for activation of T-cells family member 1 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
8.22 |
Evidence |
|
| FGFR1 |
FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor |
SOS1 |
SOS1: Son of sevenless homolog 1 |
8.22 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
CD2AP |
CD2AP: CD2-associated protein |
8.19 |
Evidence |
O
|
| IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
HSP90AA1 |
Hsp89-alpha-delta-N |
8.175 |
Evidence |
O
|
| COPZ2 |
COPZ2: Coatomer subunit zeta-2 |
COPG |
|
8.147 |
Evidence |
|
| WDR39 |
CIAO1, WDR39: Protein CIAO1 |
FAM96B |
FAM96B, CGI-128, HSPC118: Protein FAM96B |
8.13 |
Evidence |
O
|
| Pfs2 |
GINS2, PSF2, CGI-122, DC5, HSPC037: DNA replication complex GINS protein PSF2 |
SLD5 |
GINS4, SLD5: DNA replication complex GINS protein SLD5 |
8.13 |
Evidence |
O
|
| KIAA0052 |
SKIV2L2, KIAA0052: Superkiller viralicidic activity 2-like 2 |
EXOSC7 |
EXOSC7, KIAA0116, RRP42: Exosome complex exonuclease RRP42 |
8.125 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
DOK1 |
DOK1: Docking protein 1 |
8.03 |
Evidence |
|
| HDAC2 |
HDAC2: Histone deacetylase 2 |
SALL1 |
SALL1, SAL1: Sal-like protein 1 |
7.992 |
Evidence |
O
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
CTTN |
CTTN, EMS1: Src substrate cortactin |
7.977 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
IRS2 |
IRS2: Insulin receptor substrate 2 |
7.977 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
DNM2 |
IPI00218889 |
7.935 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
DAPP1 |
IPI00004301 |
7.935 |
Evidence |
|
| APOE |
APOE: Apolipoprotein E precursor |
ALB |
ALB: Uncharacterized protein ALB |
7.935 |
Evidence |
O
|
| RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
CASP8 |
IPI00305242 |
7.935 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
DEF6 |
DEF6, IBP: Differentially expressed in FDCP 6 |
7.935 |
Evidence |
|
| SQSTM1 |
SQSTM1: Uncharacterized protein SQSTM1 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
7.877 |
Evidence |
|
